A fast growing international specialist in Molecular Nuclear Medication.

The acquisition gives AAA its first direct existence in the Ireland and UK, expanding its existing expertise and companies in nuclear medicine and providing it with a recognised sales and advertising platform. AAA will also gain the privileges in the UK and Ireland to IEL's licensed SPECT radiopharmaceutical diagnostic item, IELMAG3, which can be used to image the kidneys and urinary tract.77 million, up 58 percent on the previous year. Related StoriesInnovative mini hybrid gamma ray camera increases removal of tumours and lymph nodesNew Christian Doppler Laboratory for Clinical Molecular MR Imaging opens at MedUni ViennaMallinckrodt subsidiary to obtain Therakos for $1.For the 12-month period endingJune 30, 2014, Intuniv®experienced U.S. Sales of around$668 million, regarding toIMS Healthdata. AboutActavis Actavis plc, headquartered inDublin, Ireland, is certainly a unique specialty pharmaceutical company centered on developing, manufacturing and commercializing top quality inexpensive generic and innovative branded pharmaceutical products for sufferers around the world. Actavismarkets a wide portfolio of branded and generic pharmaceuticals and evolves innovative medicines for patients suffering from illnesses principally in the central anxious system, gastroenterology, women's wellness, urology, cardiovascular, respiratory and anti-infective therapeutic categories.